Chander Singh Digwal
Memorial Sloan Kettering Cancer Center, National Institute of Pharmaceutical Education and Research Hyderabad, National Institute of Pharmaceutical Education and Research - Ahmedabad
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Heat shock proteins research · Ubiquitin and proteasome pathways · Synthesis and biological activity
About
I have extensive knowledge of organic and medicinal chemistry and its proper applications for developing target-specific chemical probes, target validation, and establishing structure-activity relationships (SAR) as well as a keen understanding of what is required to transform a molecule into a drug.
Employment
-
Memorial Sloan Kettering Cancer Center Research Associate2021 - Present
-
Memorial Sloan-Kettering Cancer Center Research Fellow2018 - 2021
Education
-
National Institute of Pharmaceutical Education and Research Hyderabad Ph. D.2012 - 2017
- 2010 - 2012
-
Mohanlal Sukhadia University B. Pharm2006 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- Synthesis and Characterization of Click Chemical Probes for Single-Cell Resolution Detection of Epichaperomes in Neurodegenerative Disorders Save
- Unraveling the Mechanism of Epichaperome Modulation by Zelavespib: Biochemical Insights on Target Occupancy and Extended Residence Time at the Site of Action Save
- Editorial: Development of selective carbon-11 radioligands for target-based PET molecular imaging in oncology, cardiology and neurology Save
- How aberrant N-glycosylation can alter protein functionality and ligand binding: An atomistic view Save
- Synthesis, biological evaluation and mechanistic studies of 4-(1,3-thiazol-2-yl)morpholine-benzimidazole hybrids as a new structural class of antimicrobials Save
- Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation Save
- Disease-specific interactome alterations via epichaperomics: the case for Alzheimer’s disease Save
- Epichaperomes as a Gateway to Understanding, Diagnosing, and Treating Disease Through Rebalancing Protein–Protein Interaction Networks Save
- How Aberrant <italic>N</italic>-Glycosylation Can Alter Protein Functionality and Ligand Binding: an Atomistic View Save
- PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective Save
- Synthesis of 124I-labeled epichaperome probes and assessment in visualizing pathologic protein-protein interaction networks in tumor bearing mice Save
- Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system Save
- Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer Save
- A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond Save
- Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignancies Save
- Design and Synthesis of 5-Morpholino-Thiophene-Indole/ Oxindole Hybrids as Cytotoxic Agents Save
- Biomarker based targeting of the epichaperome as a novel therapeutic approach for Multiple Myeloma (MM) Save
- Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors Save
- Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents Save
- Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors Save